Attovia Therapeutics, Inc. (ATTO) Insider Trading

Name: Attovia Therapeutics, Inc. (ATTO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 13, 2026): WALSH COLIN (Director): Purchase of 85,000 shares, $1.78M.

Get alerted when insiders trade ATTO

Email address

Loading company data...

Loading company details...